Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.

Lehtinen L, Vainio P, Wikman H, Reemts J, Hilvo M, Issa R, Pollari S, Brandt B, Oresic M, Pantel K, Kallioniemi O, Iljin K.

J Pathol. 2012 Mar;226(4):674-86. doi: 10.1002/path.3956. Epub 2012 Jan 17.

PMID:
22072156
[PubMed - indexed for MEDLINE]
2.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

PMID:
19123925
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

JAM-A expression positively correlates with poor prognosis in breast cancer patients.

McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM.

Int J Cancer. 2009 Sep 15;125(6):1343-51. doi: 10.1002/ijc.24498.

PMID:
19533747
[PubMed - indexed for MEDLINE]
4.

Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.

Wang XX, Zhu Z, Su D, Lei T, Wu X, Fan Y, Li X, Zhao J, Fu L, Dong JT, Fu L.

Hum Pathol. 2011 Oct;42(10):1410-9. doi: 10.1016/j.humpath.2010.12.007. Epub 2011 Mar 21.

PMID:
21419475
[PubMed - indexed for MEDLINE]
5.

Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.

Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH.

J Pathol. 2012 Oct;228(2):158-69. doi: 10.1002/path.3988. Epub 2012 May 23.

PMID:
22247069
[PubMed - indexed for MEDLINE]
6.

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

Vainio P, Gupta S, Ketola K, Mirtti T, Mpindi JP, Kohonen P, Fey V, Perälä M, Smit F, Verhaegh G, Schalken J, Alanen KA, Kallioniemi O, Iljin K.

Am J Pathol. 2011 Feb;178(2):525-36. doi: 10.1016/j.ajpath.2010.10.002.

PMID:
21281786
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.

Lehtinen L, Ketola K, Mäkelä R, Mpindi JP, Viitala M, Kallioniemi O, Iljin K.

Oncotarget. 2013 Jan;4(1):48-63.

PMID:
23295955
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cyclin D1, Id1 and EMT in breast cancer.

Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G.

BMC Cancer. 2011 Sep 28;11:417. doi: 10.1186/1471-2407-11-417.

PMID:
21955753
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.

Sin S, Bonin F, Petit V, Meseure D, Lallemand F, Bièche I, Bellahcène A, Castronovo V, de Wever O, Gespach C, Lidereau R, Driouch K.

J Natl Cancer Inst. 2011 Sep 7;103(17):1323-37. doi: 10.1093/jnci/djr290. Epub 2011 Aug 10.

PMID:
21832234
[PubMed - indexed for MEDLINE]
Free Article
10.

Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.

Wendt MK, Smith JA, Schiemann WP.

Oncogene. 2010 Dec 9;29(49):6485-98. doi: 10.1038/onc.2010.377. Epub 2010 Aug 30.

PMID:
20802523
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.

Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B.

Cancer Res. 2012 Sep 1;72(17):4597-608. doi: 10.1158/0008-5472.CAN-12-1045. Epub 2012 Jul 11.

PMID:
22787120
[PubMed - indexed for MEDLINE]
Free Article
12.

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID:
17786294
[PubMed - indexed for MEDLINE]
13.

Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells.

Hu J, Qin K, Zhang Y, Gong J, Li N, Lv D, Xiang R, Tan X.

Biochem Biophys Res Commun. 2011 Aug 12;411(4):786-91. doi: 10.1016/j.bbrc.2011.07.025. Epub 2011 Jul 21.

PMID:
21798248
[PubMed - indexed for MEDLINE]
14.

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.

Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE.

Cancer Res. 2004 Aug 15;64(16):5818-24.

PMID:
15313925
[PubMed - indexed for MEDLINE]
Free Article
15.

Vimentin expression is associated with decreased survival in gastric cancer.

Otsuki S, Inokuchi M, Enjoji M, Ishikawa T, Takagi Y, Kato K, Yamada H, Kojima K, Sugihara K.

Oncol Rep. 2011 May;25(5):1235-42. doi: 10.3892/or.2011.1185. Epub 2011 Feb 14.

PMID:
21327330
[PubMed - indexed for MEDLINE]
16.

The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.

Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.

Breast Cancer Res Treat. 2006 Sep;99(2):155-62. Epub 2006 Mar 16.

PMID:
16541304
[PubMed - indexed for MEDLINE]
17.

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, Tai HH, Karlan BY, Koeffler HP.

Cancer Res. 2006 Aug 1;66(15):7818-23.

PMID:
16885386
[PubMed - indexed for MEDLINE]
Free Article
18.

Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.

Alexopoulou AN, Leao M, Caballero OL, Da Silva L, Reid L, Lakhani SR, Simpson AJ, Marshall JF, Neville AM, Jat PS.

Breast Cancer Res. 2010;12(4):R51. doi: 10.1186/bcr2610. Epub 2010 Jul 19.

PMID:
20642837
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.

Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.

PMID:
18593909
[PubMed - indexed for MEDLINE]
Free Article
20.

Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.

Pickard MR, Green AR, Ellis IO, Caldas C, Hedge VL, Mourtada-Maarabouni M, Williams GT.

Breast Cancer Res. 2009;11(4):R60. doi: 10.1186/bcr2350. Epub 2009 Aug 11.

PMID:
19671159
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk